Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer

Pancreatic cancer accounts for nearly one fourth of all new cancers worldwide. Little progress in the development of novel or adjuvant therapies has been made over the past few decades and new approaches to the treatment of pancreatic cancer are desperately needed. Pharmacologic ascorbate (P-AscH<...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Garett J. Steers, Gloria Y. Chen, Brianne R. O’Leary, Juan Du, Hannah Van Beek, Joseph J. Cullen
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	pharmacologic ascorbate vitamin C pancreatic cancer Auranofin thioredoxin thioredoxin reductase
Online Access:	https://www.mdpi.com/2076-3921/11/5/971

Similar Items

The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug
by: Francesca Coscione, et al.
Published: (2024-07-01)

Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida
by: Jinfang Lu, et al.
Published: (2025-07-01)

Comparison of the mechanism of antimicrobial action of the gold(I) compound auranofin in Gram-positive and Gram-negative bacteria
by: Laísa Quadros Barsé, et al.
Published: (2024-11-01)

Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels
by: Xia Ying Cui, et al.
Published: (2022-08-01)

Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections
by: Alvie Loufouma-Mbouaka, et al.
Published: (2024-12-01)

Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus
by: Francesca Fata, et al.
Published: (2022-05-01)

<i>Entamoeba histolytica</i> Adaption to Auranofin: A Phenotypic and Multi-Omics Characterization
by: Yana Shaulov, et al.
Published: (2021-08-01)

New drug target in protozoan parasites: the role of thioredoxin reductase
by: Rosa M. Andrade, et al.
Published: (2015-09-01)

The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-10-01)

The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-09-01)

Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth
by: Spenser S. Johnson, et al.
Published: (2024-12-01)

Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing–Remitting EAE
by: Layla A. Al-Kharashi, et al.
Published: (2023-09-01)

Role of thioredoxin reductase (TrxB) in oxidative stress response of Francisella tularensis live vaccine strain
by: Matthew Higgs, et al.
Published: (2025-10-01)

Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
by: Juan Du, et al.
Published: (2021-04-01)

Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
by: Pierre Sabatier, et al.
Published: (2021-12-01)

The Human Thioredoxin System: Modifications and Clinical Applications
by: Seyed Isaac Hashemy
Published: (2011-03-01)

Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase
by: Nagendran Tharmalingam, et al.
Published: (2023-08-01)

Oxidized Forms of Ergothioneine Are Substrates for Mammalian Thioredoxin Reductase
by: Kaelyn A. Jenny, et al.
Published: (2022-01-01)

Determining the Rate-Limiting Step for Light-Responsive Redox Regulation in Chloroplasts
by: Keisuke Yoshida, et al.
Published: (2018-10-01)

Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells
by: Fatemeh Jamali, et al.
Published: (2024-10-01)

Pharmacologic Ascorbate Radiosensitizes Pancreatic Cancer but Radioprotects Normal Tissue: The Role of Oxidative Stress-Induced Lipid Peroxidation
by: Gloria Y. Chen, et al.
Published: (2024-03-01)

Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer
by: Garett J. Steers, et al.
Published: (2023-08-01)

New Insights into the Potential of Endogenous Redox Systems in Wheat Bread Dough
by: Nicolas Navrot, et al.
Published: (2018-12-01)

Exploring the Diversity of the Thioredoxin Systems in Cyanobacteria
by: Manuel J. Mallén-Ponce, et al.
Published: (2022-03-01)

Fluorogenic probes for thioredoxin reductase activity
by: Tendai J. Mafireyi, et al.
Published: (2021-01-01)

Selenium and Redox Enzyme Activity in Pregnant Women Exposed to Methylmercury
by: Vasco Branco, et al.
Published: (2022-11-01)

Transcriptional changes of proteins of the thioredoxin and glutathione systems in Acanthamoeba spp. under oxidative stress – an RNA approach
by: Köhsler Martina, et al.
Published: (2022-01-01)

Supplemental Ascorbate Diminishes DNA Damage Yet Depletes Glutathione and Increases Acute Liver Failure in a Mouse Model of Hepatic Antioxidant System Disruption
by: Colin G. Miller, et al.
Published: (2021-02-01)

New role for thioredoxins in plants: Implication of TRXo1 in protein depersulfidation
by: Sabrina De Brasi-Velasco, et al.
Published: (2025-05-01)

Redox Regulation of Monodehydroascorbate Reductase by Thioredoxin y in Plastids Revealed in the Context of Water Stress
by: Hélène Vanacker, et al.
Published: (2018-12-01)

A Redundant System of Thioredoxin and Glutathione Is Essential for Pancreatic Acinar IntegritySummary
by: Henrik Einwächter, et al.
Published: (2025-01-01)

Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif
by: Wuyang Shi, et al.
Published: (2024-04-01)

Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition
by: Sicong Wang, et al.
Published: (2022-03-01)

Fluorescent Probes for Mammalian Thioredoxin Reductase: Mechanistic Analysis, Construction Strategies, and Future Perspectives
by: Zilong Song, et al.
Published: (2023-08-01)

Synergistic effect of thioredoxin and its reductase from Kluyveromyces marxianus on enhanced tolerance to multiple lignocellulose-derived inhibitors
by: Jiaoqi Gao, et al.
Published: (2017-10-01)

Characterization and enzymatic function of thioredoxin glutathione reductase in Orientobilharzia turkestanicum isolated from Xizang
by: Wenqiang Tang, et al.
Published: (2025-08-01)

Thioredoxin reductase from Bacillus cereus exhibits distinct reduction and NADPH‐binding properties
by: Marita Shoor, et al.
Published: (2021-11-01)

Biochemical and Kinetic Study for the Partial Purified Thioredoxin Reductase from Healthy Human Serum
by: Luay A. Al-Helaly, et al.
Published: (2023-02-01)

Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
by: Holly C. May, et al.
Published: (2018-03-01)

Inhibition of Thioredoxin Reductase Activity and Oxidation of Cellular Thiols by Antimicrobial Agent, 2-Bromo-2-nitro-1,3-propanediol, Causes Oxidative Stress and Cell Death in Cultured Noncancer and Cancer Cells
by: Chao Jiang, et al.
Published: (2025-05-01)